Items Tagged ‘colorectal cancer’
July 5, 2016
Looking for Clues About How Colorectal Cancer Develops
By Sharon Rosen 
Our bodies are home to around 100 trillion microbes, mostly bacteria, inside and out. Within the human body, microbial genes outnumber human genes 100 to 1. This is the microbiome — and we couldn’t live without it. There are diverse, complex communities of microbes in the intestines, in the mouth, on the skin and elsewhere, living […]
Tags: colorectal cancer, Dr. Nicholas Chia, Dr. Vanessa Hale, Gut Microbiome, Mayo Clinic Center for Individualized Medicine, microbiome, whole genomic sequencing
March 29, 2016
Mayo Clinic Expert Shares Five Things to Know About Colorectal Cancer
By Jeff Briggs
March is Colon and Rectal Cancer Awareness Month Roughly 140,000 people are diagnosed with colorectal cancer in the U.S. each year. It is the third most common cancer and No. 2 cause of cancer-related deaths among men and women. Heidi Nelson, M.D., chief of surgery at Mayo Clinic, and director of the Mayo Clinic Center […]
Tags: Biobank, center for individualized medicine, ColoGuard, colon cancer, colorectal, colorectal cancer, Dr. Heidi Nelson, Precision Medicine, rectal cancer
September 2, 2014
Mayo Clinic First to Offer Stool-Based DNA Screening Test for Colorectal Cancer
By Center for Individualized Medicine
Exact Sciences Corp. recently announced that Mayo Clinic will be the first health system to offer Cologuard®, the first and only Food and Drug Administration (FDA) approved, noninvasive stool DNA screening test for colorectal cancer. Cologuard will be available to patients through their primary care physicians at Mayo Clinic. Available by prescription only, Cologuard offers […]
Tags: biomarker, biomarkers, cancer, center for individualized medicine, ColoGuard, colon cancer, colorectal, colorectal cancer, David Ahlquist, DNA, DNA Sequencing, dna test
October 3, 2013
By AJ Montpetit
“Individualized Medicine is no longer the stuff of science fiction.” —Richard Weinshilboum, M.D., Pharmacogenomic Program director and conference co-director This quote from pioneering , Richard Weinshilboum, M.D., set the tone for Individualizing Medicine 2013: From Promise to Practice. With more than 750 physicians, researchers, scientists, medical staff, genetic counselors and others gathering in Rochester to exchange ideas, it’s […]
Tags: Bioethics, breast cancer, c. difficile, cancer, center for individualized medicine, colon cancer, colorectal cancer, DNA, exome, fecal transplant, gene sequencing, genetic
September 5, 2013
Molecular Biomarkers to Inform Adjuvant Therapy for Lynch Syndrome
By AJ Montpetit
The most common hereditary colon cancer disorder, Lynch syndrome, increases the risk of colorectal cancer (CRC) and are usually caused by germline mutations in 1 of 4 mismatch repair (MMR) genes: MLH1, MSH2, MSH6 and PMS2. Identifying people who are at risk is important for their care, as well as the care of members of […]
Tags: biomarker, biomarkers, cancer, colorectal cancer, Genetics, genome, genomics, individualized medicine, lynch syndrome, molecular biomarkers
August 30, 2013
Colorectal Cancer Screenings Future
By AJ Montpetit
Colorectal cancer (CRC) remains the second-leading cause of cancer deaths in the United States, and a new multi-marker test for stool DNA (sDNA) developed by Mayo Clinic in collaboration with Exact Sciences Corp. of Madison, Wis., has seen improvements to the effectiveness of screening for CRC and reducing risk. No special preparations are needed for the […]
Tags: cancer screening, center for individualized medicine, colon cancer, colorectal cancer, Exact Science, individualized medicine, mayo clinic, screening, sDNA